FDA Warns Against Unverified Compounded Weight Loss Medications

The FDA has issued warnings regarding compounded versions of weight loss drugs like semaglutide and tirzepatide. Due to supply shortages, some pharmacies are creating these without full verification, potentially leading to incorrect dosages or impurities. Patients are advised to obtain medications only from licensed clinicians and verified pharmacies to ensure safety.